IP Litigation > Nova Content
Written by Scott Raevsky and David Schmidt, Ph.D.
The PTAB issued an order applying collateral estoppel to determine that one purported owner of U.S. Patent... Read More »
Written by Linda Xu and Kerry S. Taylor, Ph.D.
The PTAB issued a Final Written Decision finding that Biogen’s patent on treating Multiple Sclerosis... Read More »
Written by Scott Raevsky and Mark Rubinshtein, Ph.D.
The Patent Trial and Appeal Board issued concurrent final written decisions upholding the validity of all... Read More »
Written by Peter Heuser, Schwabe Williamson & Wyatt
In Nidec v. Zhongshan, the panel reverses a determination of anticipation, noting that the Circuit’s ... Read More »
Written by Daniel K. Yarbrough, Ph.D. and Kerry S. Taylor, Ph.D.
Bevacizumab (Avastin®) is the subject of the widely watched “patent dance”... Read More »
Written by Damien Howard and Nathanael Luman, Ph.D.
The Patent Trial and Appeal Board (“PTAB”) invoked its discretion under 35 U.S.C. § 325(d) to ... Read More »
Written by Chang Lim and Lincoln S. Essig
The Federal Circuit recently clarified what patents are subject to the Transitional Program for Covered Business Method... Read More »
Couple of weeks ago we reported that Zond ranked first among patent owners with 125 IPR challenges filed against 10 of its patents. This week we delved into the... Read More »
Written by Casey D. Donahoe, Ph.D. and Kerry S. Taylor, Ph.D.
The Patent Trial and Appeal Board granted a rare request for rehearing of its earlier decision... Read More »
It has been a busy week at the Circuit. In Comcast v. Sprint the Circuit affirms a $7.5 million judgment that includes prejudgment interest running from the date ... Read More »
Written by Neil G. Anderson and Benjamin Anger
The Federal Circuit affirmed the PTAB’s final written decision holding that claims from Michael... Read More »
Written by Mark E. Davis and Kerry S. Taylor, Ph.D.
The PTAB issued two final written decisions upholding The University of Pennsylvania’s claims to methods ... Read More »
Last week, we released the top 10 patent owners whose patents had been challenged the most since the inception of Inter-Partes Review (IPR). Zond ranked first with a... Read More »
Written by Damien Howard and Michael L. Fuller
Is a patent directed to electronic communications between computing devices patent eligible? As with many... Read More »
Eli Lilly is not likely to think of the Circuit’s handling of its successful IPR as an “intimate moment,” given that the Circuit reversed a... Read More »
Written by Sabrina Wang and Adam Powell
The Federal Circuit held that a rat study in a provisional application and a conversion method in an uncited reference did ... Read More »
Written by Diana E. Wade and Bridget A. Smith
The Federal Circuit held that the PTAB may consider legal conclusions of obviousness by experts, but the expert... Read More »
Written by Scott Raevsky and David T. Kim
In a final written decision, the Board denied a patent owner’s request for a certificate of correction filed... Read More »
The last few weeks, our Data Science Team analyzed the most active petitioners in Inter-Partes Review (IPR) cases. Now we have turned our attention towards the patent ... Read More »
Written by Kerry S. Taylor, Ph.D. and Nathanael Luman, Ph.D.
The PTAB issued a Final Written Decision upholding Pozen’s ulcer reducing Vimovo® claims... Read More »